Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

Publication date: Available online 30 April 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Konrad Rejdak, Paweł Grieb

Source: Multiple Sclerosis and Related Disorders - April 30, 2020 Category: Neurology Source Type: research